share_log

Novavax | 4: Statement of changes in beneficial ownership of securities-Officer Draghia-Akli Ruxandra

Novavax | 4: Statement of changes in beneficial ownership of securities-Officer Draghia-Akli Ruxandra

诺瓦瓦克斯医药 | 4:持股变动声明-高管 Draghia-Akli Ruxandra
美股SEC公告 ·  11/14 05:15

Moomoo AI 已提取核心信息

Novavax Inc. (NVAX) reported a transaction involving Ruxandra Draghia-Akli, a person with a Section 16 relationship to the issuer, according to a recent filing. The transaction occurred on 11/11/2024. However, the filing did not disclose specific details such as the action type, status, number of shares, nature of shares, transaction price, or the total value of shares involved. The number of shares held by Draghia-Akli after the action was also not provided. Investors are advised to await further details to fully assess the impact of this transaction on their investment decisions.
Novavax Inc. (NVAX) reported a transaction involving Ruxandra Draghia-Akli, a person with a Section 16 relationship to the issuer, according to a recent filing. The transaction occurred on 11/11/2024. However, the filing did not disclose specific details such as the action type, status, number of shares, nature of shares, transaction price, or the total value of shares involved. The number of shares held by Draghia-Akli after the action was also not provided. Investors are advised to await further details to fully assess the impact of this transaction on their investment decisions.
诺瓦瓦克斯股份有限公司(NVAX)报告了涉及与发行人存在第16条关系的拉克西亚·德拉格亚-阿克利(Ruxandra Draghia-Akli)的交易,根据最近的申报。该交易发生在2024年11月11日。然而,该申报未披露具体细节,如行动类型、状态、股票数量、股票性质、交易价格或涉及的股票总价值。拉克西亚·德拉格亚-阿克利在此次行动后持有的股票数量也未提供。建议投资者等待进一步细节,以充分评估该交易对其投资决策的影响。
诺瓦瓦克斯股份有限公司(NVAX)报告了涉及与发行人存在第16条关系的拉克西亚·德拉格亚-阿克利(Ruxandra Draghia-Akli)的交易,根据最近的申报。该交易发生在2024年11月11日。然而,该申报未披露具体细节,如行动类型、状态、股票数量、股票性质、交易价格或涉及的股票总价值。拉克西亚·德拉格亚-阿克利在此次行动后持有的股票数量也未提供。建议投资者等待进一步细节,以充分评估该交易对其投资决策的影响。
声明:本内容仅用作提供资讯及教育之目的,不构成对任何特定投资或投资策略的推荐或认可。 更多信息